Eton Pharmaceuticals Inc (NAS:ETON)
$ 3.67 0.1 (2.78%) Market Cap: 94.28 Mil Enterprise Value: 80.85 Mil PE Ratio: 92.50 PB Ratio: 6.17 GF Score: 58/100

Q3 2022 Eton Pharmaceuticals Inc Earnings Call Transcript

Nov 10, 2022 / 09:30PM GMT
Release Date Price: $2.51 (-1.18%)
Operator

Good afternoon, and welcome to Eton Pharmaceuticals' third-quarter 2022 financial results conference call. (Operator Instructions) Please be advised that this call is being recorded at the company's request.

At this time, I would like to turn it over to David Krempa, Senior Vice President of Business Development and Investor Relations at Eton Pharmaceuticals. Please proceed.

David Krempa
Eton Pharmaceuticals, Inc. - SVP, Business Development & IR

Thank you, operator. Good afternoon, everyone, and welcome to Eton's third-quarter 2022 conference call. This afternoon, we issued a press release that outlines the topics we plan to discuss on today's call. The release is available on our website, etonpharma.com.

Joining me on our call today, we have Sean Brynjelsen, our CEO; and James Gruber, our CFO. In addition to taking live questions on today's call, we will also be answering questions that are e-mailed to us. Investors can send their questions to [email protected].

Before we begin, I would like to remind everyone

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot